- Public Comps
- Ludwig Enterprises
Ludwig Enterprises Valuation Multiples
Discover revenue and EBITDA valuation multiples for Ludwig Enterprises and similar public comparables like Monsenso, Centogene, Induct, Aino Health and more.
Ludwig Enterprises Overview
About Ludwig Enterprises
Ludwig Enterprises Inc is a publicly traded Medical Technology Holding Company with Precision Genomics, Inc. and MyRNA for Life, Inc. as wholly owned subsidiaries. The company's advancements in medical technology and Artificial Intelligence (AI) have awarded it with cutting-edge genomic tools. These genomic tools have the potential to detect diseases early but also to customize treatments that may improve patient outcomes and, in some cases, even extend life. Ludwig is at the forefront of this new era with their proprietary mRNA genetic technology that has the potential to detect genetic biomarkers for inflammatory-driven diseases, including but not limited to heart disease, diabetes, preeclampsia, and cancer. It manages its business on the basis of one operating and reportable segment.
Founded
1988
HQ

Employees
3
Website
Financials (FY)
EV
$6M
Valuation Multiples
Start free trialLudwig Enterprises Financials
Ludwig Enterprises reported last fiscal year revenue of - and negative EBITDA of ($1M).
In the same fiscal year, Ludwig Enterprises generated ($1M) in EBITDA losses and had net loss of ($2M).
Ludwig Enterprises P&L
In the most recent fiscal year, Ludwig Enterprises reported revenue of - and EBITDA of ($1M).
Ludwig Enterprises is unprofitable as of last fiscal year, with EBITDA margin of - and net margin of -.
Financial data powered by Morningstar, Inc.
Ludwig Enterprises Stock Performance
Ludwig Enterprises has current market cap of $3M, and enterprise value of $6M.
Market Cap Evolution
Ludwig Enterprises' stock price is $0.02.
Ludwig Enterprises share price decreased by 70.4% in the last year.
Ludwig Enterprises has an EPS (earnings per share) of $-0.01.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $6M | $3M | 0.0% | 0.0% | -43.4% | -70.4% | $-0.01 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialLudwig Enterprises Valuation Multiples
Ludwig Enterprises trades at (4.4x) EV/EBITDA.
Ludwig Enterprises Financial Valuation Multiples
As of July 19, 2026, Ludwig Enterprises has market cap of $3M and EV of $6M.
Ludwig Enterprises has a P/E ratio of (1.5x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Ludwig Enterprises Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Ludwig Enterprises Margins & Growth Rates
Ludwig Enterprises Margins
Ludwig Enterprises Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Ludwig Enterprises Operational KPIs
Ludwig Enterprises' revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.6M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
Ludwig Enterprises Competitors
Ludwig Enterprises competitors include Monsenso, Centogene, Induct, Aino Health, Telemedycyna Polska, Lifeline Biotechnologies, TALI Digital, 2cureX, Allurion and Integragen.
Most Ludwig Enterprises public comparables operate across Diagnostics & Genomics, Health Data & Analytics, DeepTech and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 2.8x | - | (8.5x) | - | |||
| 1.4x | - | (3.4x) | - | |||
| 1.7x | 1.7x | 3.7x | 3.9x | |||
| 1.6x | - | (17.7x) | - | |||
| 1.6x | - | (6.6x) | - | |||
| - | - | - | - | |||
| 1540.9x | - | (2.6x) | - | |||
| - | - | (9.0x) | - | |||
This data is available for Pro users. Sign up to see all Ludwig Enterprises competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Ludwig Enterprises
| When was Ludwig Enterprises founded? | Ludwig Enterprises was founded in 1988. |
| Where is Ludwig Enterprises headquartered? | Ludwig Enterprises is headquartered in United States. |
| How many employees does Ludwig Enterprises have? | As of today, Ludwig Enterprises has over 3 employees. |
| Is Ludwig Enterprises publicly listed? | Yes, Ludwig Enterprises is a public company listed on OTCM. |
| What is the stock symbol of Ludwig Enterprises? | Ludwig Enterprises trades under LUDG ticker. |
| When did Ludwig Enterprises go public? | Ludwig Enterprises went public in 2007. |
| Who are competitors of Ludwig Enterprises? | Ludwig Enterprises main competitors include Monsenso, Centogene, Induct, Aino Health, Telemedycyna Polska, Lifeline Biotechnologies, TALI Digital, 2cureX, Allurion, Integragen. |
| What is the current market cap of Ludwig Enterprises? | Ludwig Enterprises' current market cap is $3M. |
| Is Ludwig Enterprises profitable? | No, Ludwig Enterprises is not profitable. |
| How many companies Ludwig Enterprises has acquired to date? | Ludwig Enterprises hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Ludwig Enterprises has invested to date? | Ludwig Enterprises hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Ludwig Enterprises
Lists including Ludwig Enterprises
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




